Latest News & Features
Refine Search
Americas
 In the area of precision medicine, there are questions surrounding what data is needed, how it is used, what it should look like and what concerns there are for patients and society, as Daniel Lim of Kirkland & Ellis reports.   17 July 2018 
Americas
 The US Court of Appeals for the Federal Circuit has rejected Jazz Pharmaceuticals’ attempt to revive patents covering its narcolepsy drug Xyrem.   17 July 2018 
Americas
 The US Court of Appeals for the Federal Circuit confirmed the validity of two patents covering a testosterone replacement therapy on Friday, July 13, in a win for Bayer Pharma and Endo Pharmaceuticals Solutions.   16 July 2018 
Big Pharma
 While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers.   16 July 2018 
Americas
 Healthcare investment yields the best returns when focusing on its core aims and forging strong partnerships, James Flynn, managing partner of Deerfield, tells LSIPR.   16 July 2018 
Biotechnology
 As the  Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren  are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.   13 July 2018 
Americas
 McDermott Will & Emery has strengthened its IP team with the addition of a former DLA Piper partner.   13 July 2018 
Americas
 A former employee pleaded guilty to stealing trade secrets from what is now the world’s largest chemicals company earlier this week.   13 July 2018 
Americas
 BMS’s teams are working to answer key questions and more intimately understand the interplay between the immune system and cancer, Paul Golian, vice president and assistant counsel of IP at BMS, tells LSIPR.   13 July 2018 
Americas
 Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.   12 July 2018 


